Process optimization for recombinant Marburg Virus Glycoprotein production using Drosophila S2 Cells

Authors

• Sven Goebel, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, GermanyFollow
• Earl Pineda, Repligen, Waltham, MA, United States
• Michael Keebler, Kuhner Shaker Inc., San Carlos, USA
• Tibor Anderlei, Adolf Kühner AG, Switzerland
• Yvonne Genzel, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg
• Udo Reichl, Max Planck Institute for Dynamics of Complex Technical Systems & Otto-von-Guericke University, Magdeburg, Germany
• Axel T. Lehrer, Department of Tropical Medicine, Medical Microbiology & Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, United States

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Sven Goebel, Earl Pineda, Michael Keebler, Tibor Anderlei, Yvonne Genzel, Udo Reichl, and Axel T. Lehrer, "Process optimization for recombinant Marburg Virus Glycoprotein production using Drosophila S2 Cells" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/91